Acceptability of subdermal implants and Tcu 380 A IUD in Alexandria

A total of 110 implants and 100 IUD adopters were followed up for one year at 3-month interval visits. Data were collected using interview questionnaires, menstrual diary cards, clinical examination and investigations including cervical Pap smear and hemoglobin concentration. Results indicated that the subdermal implants system was as frequently requested and acceptable by women as the well known IUD. The net cumulative continuation rate of implants was higher than that of the IUD at the end of the first year of use [95.4/100 women vs 88.4/100]. More than three-fourths of implants users and 83.33% of IUD continuers perceived no general health problems due to the method used. About 70% of continuers in both groups perceived no significant or intolerant change in their menstrual pattern. Headaches and weight gain were the most common nonmenstrual hormone related complaints among the implants users. Low backaches and lower abdominal pains were the most frequently reported side effects among the IUD group. At the end of the first year of use, about 93% on Norplant and IUD continuers were highly satisfied with their adopted method attributing their satisfaction mainly to the method effectiveness

Motivos de retiro de implantes norplant

Objetivo: Conocer si los efectos secundarios de los implantes anticonceptivos subdérmicos a base de Levanorgestel: Norplant son motivo de retiro. Material y Métodos: Comprende 7.776 implantes colocados entre abril/30/86 a agosto 31/93(88 meses). Se realizaron 1859 retiros por motivos descritos por las usuarias (23.90 por ciento). El estudio Institucional se agrupó en cinco categorías. Resultados: I. Motivo esperado de retiro: 681 pac. (36.63 por ciento); a) Deseo de embarazo:378 pac.(55.50 por ciento); b)Cumplieron los cinco años de uso: 257 pac.(37.73 por ciento); c) Cambio de Método: 46 pac. (6.75 por ciento). II. retiro de Norplant por un motivo(médicos o extramédicos) 958 pac. (51.53 por ciento). III. Retiro de Norplant por dos motivos: 192 pac. (10.32 por ciento).IV.Retiro por tres motivos: 24 pac.(1.29 por ciento).V_. Retiro pos cuatro motivos. 4 pac.(0.21 por ciento). Hallazgo Sobresaliente: II. Mótivo único: 958 pac. (51.61 por ciento): Disfunciones mestruales: 329 pac. (34.34 por ciento); Médicos Generales, 198 pac. (20.66 por ciento); especialidades médicas: 125 pac. (13.02 por ciento); cefalea: 117 pac. (12.21 por ciento); motivos personales; 101 pac.(10.54 por ciento); várices: 55 pac. (5.74 por ciento); embarazo: 33 pac. (3.44 popr ciento). Conclusión: Efectos secundarios:relativos. Prima un motivo de retiro. Continuidad de uso de 76.10 por ciento